Brent Hatzis Schoch Black Diamond Therapeutics, Inc. (BDTX) insider trading activity

Brent Hatzis Schoch is of Black Diamond Therapeutics, Inc.. Currently has a direct ownership of 83,400 shares of BDTX, which is worth approximately $208,500. The most recent transaction as insider was on Jan 30, 2025, when has been sold 75,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 83.4K

892.86% 3M change

892.86% 12M change

Total Value Held $208,500

Brent Hatzis-Schoch Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 30 2025	BUY Grant, award, or other acquisition	-	75,000 Added 47.35%	83,400 Common Stock
May 12 2021	SELL Open market or private sale	$111,737 $27.4 p/Share	4,078 Reduced 32.68%	8,400 Common Stock
May 12 2021	BUY Exercise of conversion of derivative security	$13,050 $3.2 p/Share	4,078 Added 24.63%	12,478 Common Stock
Apr 12 2021	SELL Open market or private sale	$101,950 $25.0 p/Share	4,078 Reduced 32.68%	8,400 Common Stock
Apr 12 2021	BUY Exercise of conversion of derivative security	$13,050 $3.2 p/Share	4,078 Added 24.63%	12,478 Common Stock
Mar 12 2021	SELL Open market or private sale	$107,496 $26.36 p/Share	4,078 Reduced 32.68%	8,400 Common Stock
Mar 12 2021	BUY Exercise of conversion of derivative security	$13,050 $3.2 p/Share	4,078 Added 24.63%	12,478 Common Stock
Feb 12 2021	SELL Open market or private sale	$111,860 $27.43 p/Share	4,078 Reduced 32.68%	8,400 Common Stock
Feb 12 2021	BUY Exercise of conversion of derivative security	$13,050 $3.2 p/Share	4,078 Added 24.63%	12,478 Common Stock
Jan 12 2021	SELL Open market or private sale	$376,169 $32.49 p/Share	11,578 Reduced 57.95%	8,400 Common Stock
Jan 12 2021	BUY Exercise of conversion of derivative security	$81,393 $7.03 p/Share	11,578 Added 36.69%	19,978 Common Stock
Dec 28 2020	BUY Exercise of conversion of derivative security	$17,280 $3.2 p/Share	5,400 Added 39.13%	8,400 Common Stock
Dec 14 2020	SELL Open market or private sale	$142,526 $34.95 p/Share	4,078 Reduced 57.62%	3,000 Common Stock
Dec 14 2020	BUY Exercise of conversion of derivative security	$13,050 $3.2 p/Share	4,078 Added 36.55%	7,078 Common Stock
Nov 12 2020	SELL Open market or private sale	$139,631 $34.24 p/Share	4,078 Reduced 57.62%	3,000 Common Stock
Nov 12 2020	BUY Exercise of conversion of derivative security	$13,050 $3.2 p/Share	4,078 Added 36.55%	7,078 Common Stock
Oct 12 2020	SELL Open market or private sale	$135,308 $33.18 p/Share	4,078 Reduced 57.62%	3,000 Common Stock
Oct 12 2020	BUY Exercise of conversion of derivative security	$13,050 $3.2 p/Share	4,078 Added 36.55%	7,078 Common Stock

Brent Hatzis Schoch

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDTX shares.

Notify only if

Value

Insider Trading

Get notified when an Black Diamond Therapeutics, Inc. insider buys or sells BDTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Black Diamond Therapeutics, Inc.

Track Activities on BDTX

Account